Posted in | News | Chemistry

Analysis on Chemical Businesses of Reliance Industries

Chemical Market Associates, Inc. (CMAI): CMAI's Chemical Company Analysis (CCA) on Reliance Industries, the second company report of the 2010 Edition, is now available.

The report features comprehensive overviews of the chemical businesses of Reliance Industries, including strategic direction and corporate structure; global chemical operations, and business positions of Reliance Industries and its competitors within major product markets; manufacturing site flowcharts and descriptions; as well as vertical product integration and market exposure.

The report aims at providing clients with a thorough understanding of not only the present situation, but also the impact of future developments by assessing Reliance Industries' opportunities and risks within the framework of CMAI's outlook for the global petrochemical industry. Rapidly changing industry structure and dynamics will necessitate company-specific responses that will determine the success of chemical producers in the future.

Reliance Industries Limited (RIL) remains by far the largest private corporation in India, presenting 5.6 percent of indirect government tax revenues and 14.5 percent of India's total exports. RIL is a Fortune Global 500 company, ranking in at the 175th position. Revenues reported at close to U.S. $45 billion for the financial year 2009/10 (April to March) will likely increase to well over U.S. $50 billion in 2010/11. With globally competitive capital and operating cost positions, Reliance Industries dominates the rapidly growing Indian market and enjoys a large presence in the international market for petrochemicals and refining products.

The Group's activities range from oil and gas exploration and production, refining and marketing, petrochemicals, fibers & textiles, retail stores, Special Economic Zones (SEZ) and more recently also solar power and broadband services. Reliance, for many of its core petrochemicals businesses, ranks among the top ten chemical producers worldwide. The company's rapidly expanding polypropylene production, based mainly on refinery propylene, is one of the most attractive products in its portfolio. The company occupies a similarly advantaged position in the polyester fibers chain, although global oversupply currently weighs on the market and makes it structurally less attractive. Domestically, however, Reliance can take advantage of rapidly rising living standards and a vast consumer base.

The Chemical Company Analysis (CCA) is a multi-client service aimed at analyzing the structure, dynamics, competition and strategic issues of global and regional chemical industry participants. The 2010 Edition includes company reports on Bayer MaterialScience, Reliance Industries, BASF SE, and Dow Chemical.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Reliance Industries Limited. (2019, February 10). Analysis on Chemical Businesses of Reliance Industries. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=26859.

  • MLA

    Reliance Industries Limited. "Analysis on Chemical Businesses of Reliance Industries". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=26859>.

  • Chicago

    Reliance Industries Limited. "Analysis on Chemical Businesses of Reliance Industries". AZoM. https://www.azom.com/news.aspx?newsID=26859. (accessed November 21, 2024).

  • Harvard

    Reliance Industries Limited. 2019. Analysis on Chemical Businesses of Reliance Industries. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=26859.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.